Ascendis Pharma - Rasio total nilai perusahaan marang pendapatan ASND

Logo perusahaan publik Ascendis Pharma (ASND)

Demand for endocrine drugs is growing rapidly, as confirmed by the company's EV/Sales valuation, which currently stands around 11604.55. This chart highlights the success of the TransCon technology, which reduces injection frequency. The innovative long-acting ecosystem secures loyalty among patients with rare pathologies, providing Ascendis Pharma A/S (ASND) a sustainable advantage in metabolic therapy.

ASND Ascendis Pharma A/S: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 20.11.2026

ASND (Ascendis): rincian analitis lan laporan miturut indikator

- rega saham lan prakiraan rega para ahli:
Pambiji fundamental perusahaan:Ascendis Pharma A/S
Produk seri Ascendis Pharma Inc.

For Ascendis Pharma A/S, the EV/Sales metric reflects the enterprise value of the business relative to its generated revenue stream. By analyzing the EV/Sales history, an investor sees the current ratio of 11604.55, which compares the actual sales of Skytrofa with the company's capitalization. The high value of this indicator confirms that the market has already priced in the future commercial success of new metabolic molecules.

Analisis pesaing Ascendis Pharma A/S

MDGL: Rasio nilai perusahaan marang pendapatan|CORT: Multiplikator EV/Sales|RYTM - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Akero Corp|Metsera Therapeutics (MTSR) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan moonlaketx.com (MLTX)|Nilai perusahaan marang pendapatan Crinetics Pharmaceuticals CRNX|Rasio nilai perusahaan marang pendapatan NewAmsterdam Pharma N.V. NAMS|Rasio total nilai perusahaan marang pendapatan Soleno Therapeutics Inc (SLNO)|FOLD - Rasio nilai perusahaan marang pendapatan|ETNB: Rasio nilai perusahaan marang pendapatan|AGIO: Multiplikator EV/Sales|Structure Therapeutics Inc. - Nilai bisnis marang pendapatan|MDXG (MiMedx Corp) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Rezolute Inc RZLT|Multiplikator EV/Sales LXRX|Rasio total nilai perusahaan marang pendapatan MBX Corp|Altimmune Pharma - Nilai perusahaan marang pendapatan|Multiplikator EV/Sales aardvarktherapeutics.com AARD|SGMT: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan BIOA (BioAge Labs)|BMEA: Multiplikator EV/Sales|QNCX: Koefisien nilai perusahaan marang pendapatan|GUTS (Fractyl Health, Inc.) - Multiplikator EV/Sales|Multiplikator EV/Sales vtvtherapeutics.com|Nilai perusahaan marang pendapatan ATPC (Agape ATP Corp)|Rasio total nilai perusahaan marang pendapatan Pluristem Therapeutics|Rasio nilai perusahaan marang pendapatan synlogictx.com SYBX|LPCN: Rasio nilai perusahaan marang pendapatan|MTNB - Rasio nilai perusahaan marang pendapatan|Spruce Biosciences, Inc. (SPRB) - Nilai perusahaan marang pendapatan|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)